Pascal Brenneisen becomes. Chairman of the Board of Directors. of Entourage Pharma Consulting AG.

After more than 3 years on the Board of Directors, Pascal Brenneisen becomes Chairman of the Board of Directors of Entourage Pharma Consulting AG.

Basel, 1 February 2020. 

Pascal Brenneisen becomes Chairman of the Board of Entourage Pharma Consulting AG, based in Basel, Switzerland.
Pascal Brenneisen has over 30 years of experience in the pharmaceutical, IT and life science industries. In addition, Mr Brenneisen is involved in various start-ups in the medical technology and pharmaceutical industries. Pascal Brenneisen will become Chairman of the Board of Directors of Entourage Pharma Consulting AG with effect from 1 February 2020.  

Testimonials.

Dominik M. Aumer, Managing Partner of Entourage GmbH and member of the Board of Directors of Entourage Pharma Consulting AG, is pleased to have won Mr Brenneisen for the new role.  

"Mr Brenneisen has proven to be a real added value for Entourage as a member of the Board of Directors. His decades of life science experience and high level of strategic expertise is an important element in Entourage's growth strategy in the Swiss market. We look forward to working with him on the Board in his new role as Chairman."  

Pascal Brenneisen, new board member of the Swiss entity, highlights the entourage perspective. "Big Pharma outsources corporate divisions in order to be able to react flexibly and nimbly as a large organisational unit to the ever faster changing framework conditions. For me, Entourage is one of the very few providers that can satisfy the resulting need for highly qualified natural scientists via flexible models. I would like to help the company shape this new working world with my many years of experience and my high level of design competence!" 

Short profile Pascal Brenneisen.

Pascal Brenneisen studied law at the University of Basel and completed further training at INSEAD, IMD Lausanne and Harvard Business School.
Mr Brenneisen has 30+ years of experience in the pharmaceutical, life science and IT industries, including 16 years as Managing Director or Regional Head. He has held positions including CEO Novartis Switzerland, EMEA Regional Head at Shire Pharmaceuticals and European Head of Hewlett Packard Enterprise Services. In addition, Mr Brenneisen is involved in various start-ups in the medical technology and pharmaceutical industries.
Pascal Brenneisen supports Entourage Pharma Consulting AG as Chairman of the Board of Directors. 

Short profile Entourage.

Entourage is a management and personnel consultancy with a focus on pharmaceuticals, medical technology and healthcare. Entourage is a management and personnel consultancy with a focus on pharmaceuticals, medical technology and healthcare. With the placement of permanent scientific employees and consultants, the Munich and Basel-based company recruits experts for the leading life science companies in the DACH region. With Project Consultants, Entourage realises projects for its clients through highly qualified temporary staffing and work contracts. With Management Consultants, Entourage bundles selected interim managers and consultants into a top-class consulting unit that realises pharmaceutical and medical technology solution scenarios in projects on an interdisciplinary basis.

Share article.

Facebook
Twitter
LinkedIn
XING
WhatsApp
E-mail

Newsletter.

Read more.

Entourage expands. With Philipp Eleftheriadis. In Switzerland.
Entourage welcomes Philipp Eleftheriadis as Senior Sales ...
Entourage expands. With Christian Fritz. In Switzerland.
Personnel and management consultancy Entourage welcomes Christian Fritz as of 1 April ...
Entourage appoints. Head of Finance Kris Hofmann. As authorised signatory.
Kris Hofmann, Head of Finance at Entourage for many years, receives power of attorney.
Entourage wins Dr Thomas Nothegger as a member of the advisory board.
Dr Thomas Nothegger becomes a member of the Advisory Board in the new year ...
Entourage wins. Dr Markus Boehringer. As medical technology advisor.
Dr Markus Boehringer becomes Entourage advisory board member in the field of medical technology.